Journal List > J Korean Soc Transplant > v.29(2) > 1034477

J Korean Soc Transplant. 2015 Jun;29(2):49-53. Korean.
Published online June 30, 2015.
Copyright © 2015 The Korean Society for Transplantation
Metabolomics Research in Kidney Transplantation
Yu Ho Lee, M.D.,1 and Sang Ho Lee, M.D.2
1Department of Nephrology, Kyung Hee University College of Medicine, Seoul, Korea.
2Department of Nephrology, Kyung Hee University Hospital at Gangdong, Seoul, Korea.

Corresponding author: Sang Ho Lee. Department of Nephrology, Kyung Hee University Hospital at Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 134-727, Korea. Tel: 82-2-440-6121, Fax: 82-2-440-6121, Email:
Received June 04, 2015; Revised June 08, 2015; Accepted June 08, 2015.


Acute and chronic immune injury, drug toxicity, and cardiovascular complications remain a critical challenge following kidney transplantation. Success from these hurdles is closely associated with the ability to monitor patients and responsively adjust their medication. Metabolic and biochemical profiling (metabolomics) may enable detection of early changes in cell signal transduction regulation and biochemistry with high sensitivity and specificity. However, metabolomics have not been studied extensively in the field of kidney transplantation. This review describes the basic principles of metabolomics, summarizes recent studies, and suggests future perspectives.

Keywords: Kidney transplantation; Metabolomics; Biological markers


1. Chung BC. Metabolomics in disease research. Mol Cell Biol News 2006;18:17–27.
2. Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, et al. The human urine metabolome. PLoS One 2013;8:e73076.
3. Kim SH, Yang SO, Kim KH, Km YS, Liu KH, Yoon YR, et al. Research trends, applications, and domestic research promotion stratigies of metabolomics. KSBB J 2009;24:113–121.
4. Emwas AHM, Salek RM, Griffin JL, Merzaban J. NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations. Metabolomics 2013;9:1048–1072.
5. Boccard J, Veuthey JL, Rudaz S. Knowledge discovery in metabolomics: an overview of MS data handling. J Sep Sci 2010;33(3):290–304.
6. Sugimoto M, Kawakami M, Robert M, Soga T, Tomita M. Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis. Curr Bioinform 2012;7(1):96–108.
7. Kim CD, Kim EY, Yoo H, Lee JW, Ryu do H, Noh DW, et al. Metabonomic analysis of serum metabolites in kidney transplant recipients with cyclosporine A- or tacrolimus-based immunosuppression. Transplantation 2010;90:748–756.
8. Li L, Sui W, Che W, Li W, Chen J, Li H, et al. 1H NMR-based metabolic profiling of human serum before and after renal transplantation. ASAIO J 2013;59:286–293.
9. Sui W, Huang L, Dai Y, Chen J, Yan Q, Huang H. Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS. Clin Exp Med 2010;10:259–268.
10. Wang J, Zhou Y, Xu M, Rong R, Guo Y, Zhu T. Urinary metabolomics in monitoring acute tubular injury of renal allografts: a preliminary report. Transplant Proc 2011;43:3738–3742.
11. Blydt-Hansen TD, Sharma A, Gibson IW, Mandal R, Wishart DS. Urinary metabolomics for noninvasive detection of borderline and acute T cell-mediated rejection in children after kidney transplantation. Am J Transplant 2014;14:2339–2349.
12. Zhao X, Chen J, Ye L, Xu G. Serum metabolomics study of the acute graft rejection in human renal transplantation based on liquid chromatography-mass spectrometry. J Proteome Res 2014;13:2659–2667.
13. Moers C, Varnav OC, van Heurn E, Jochmans I, Kirste GR, Rahmel A, et al. The value of machine perfusion perfusate biomarkers for predicting kidney transplant outcome. Transplantation 2010;90:966–973.
14. Hoogland ER, de Vries EE, Christiaans MH, Winkens B, Snoeijs MG, van Heurn LW. The value of machine perfusion biomarker concentration in DCD kidney transplantations. Transplantation 2013;95:603–610.
15. Bon D, Billault C, Thuillier R, Hebrard W, Boildieu N, Celhay O, et al. Analysis of perfusates during hypothermic machine perfusion by NMR spectroscopy: a potential tool for predicting kidney graft outcome. Transplantation 2014;97:810–816.
16. Diémé B, Halimi JM, Emond P, Büchler M, Nadal-Desbarat L, Blasco H, et al. Assessing the metabolic effects of calcineurin inhibitors in renal transplant recipients by urine metabolic profiling. Transplantation 2014;98:195–201.